Biosensor Detection of Bacterial Infection via Amylase

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting infection, particularly bacterial infection, often misidentify conditions due to the presence of bacteria without determining if they are causing infection, leading to unnecessary antibiotic use and resistance, and lack sensitivity and specificity in diagnosing infection sites.

Innovation Solution

A method using a biosensor device that analyzes biological samples for amylase levels, distinguishing between infection and inflammation with high sensitivity and specificity, employing electrochemical impedance spectroscopy and a graphene-based sensor to detect amylase activity and concentration, enabling accurate diagnosis of bacterial infections.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If microbiological swabbing is used to detect bacterial presence, then the presence of bacteria can be confirmed, but it cannot determine whether the bacteria are causing infection, leading to misdiagnosis

Engineering Contradiction:
Improveinfection detection accuracyVSAvoidinfection status information
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent uses amylase as an intermediary biomarker to indirectly detect bacterial infection. Instead of directly detecting bacteria, the method measures amylase enzyme activity which is released during bacterial infection, providing accurate infection status information without the need for direct bacterial identification.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces traditional microbiological culture methods with an electrochemical biosensing system. The biosensor uses electrochemical impedance spectroscopy to detect amylase activity, substituting complex mechanical/cultural methods with a streamlined electrochemical measurement approach that provides rapid and accurate infection detection.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If antibiotics are administered based on bacterial presence without confirming infection, then potential infections may be treated, but unnecessary antibiotic use increases costs and contributes to resistance

Engineering Contradiction:
Improvetreatment necessity accuracyVSAvoidantibiotic resistance
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent implements a feedback mechanism where amylase detection results directly inform treatment decisions. The biosensor provides real-time feedback on infection status, enabling clinicians to administer antibiotics only when amylase activity confirms active infection, thereby avoiding unnecessary antibiotic use and reducing resistance development.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If traditional detection methods are used, then general bacterial presence can be identified, but sensitivity and specificity for distinguishing infection from inflammation are insufficient

Engineering Contradiction:
Improveinfection vs inflammation differentiationVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies local quality by targeting a specific biomarker (amylase) that is locally produced at infection sites. The biosensor is designed to specifically detect amylase enzyme activity, providing localized infection information that distinguishes infection from general inflammation without requiring complex multi-parameter analysis.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides a highly sensitive (98%) and specific (90%) detection of bacterial infections, reducing unnecessary antibiotic use by accurately identifying infection sites and differentiating between infected and non-infected areas, thereby improving clinical diagnosis and treatment strategies.

Implementation Method 1

employing electrochemical impedance spectroscopy and a graphene-based sensor to detect amylase activity and concentration

Methodology Applied
Scientific EffectElectrochemical impedance spectroscopy: Electrical Impedance Tomography

Implementation Method 2

the biomarker is an enzyme, preferably amylase

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

an enzyme, preferably amylase

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS11453905B2Method of detecting bacterial infection in a biological sample
Publication Date: 2022.09.27 TRUBAC LTD
  • US11453905B2 patent drawing
  • US11453905B2 patent drawing
  • US11453905B2 patent drawing

AI summary

A method of indicating the presence of a bacterial infection in a biological sample is provided. The method detects a marker for infection by providing a device, the device including a biosensor, an interaction arising between the biosensor and the marker when the marker is present in the biological sample. Contacting at least a part of the biological sample with the biosensor of the device, therefore, provides analysis of the biological sample with respect to the marker by detecting for the interaction between the biosensor and the marker. A preferred marker is the enzyme amylase.